Acute Kidney Injury (Nontraumatic)
15
4
4
7
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 15 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 7 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 7 completed trials
Clinical Trials (15)
Impact of CRRT on Serum Carnitine and Micronutrient Levels
WISDOM UK: Low Dose-intensity Versus Standard Dose-intensity CRRT in Critically Ill Patients
Effect of an Intervention to Prevent Acute Kidney Injury Versus Standard Care in High-risk Patients After Major Surgery
Renin Angiotensin Aldosterone System In Septic Kids
AKI Risk Factors Analysis After Intentional Hypotensive Anesthesia
A New Marker for Early Diagnosis of Pneumoperitoneum-Related Acute Kidney Injury: Insulin-Like Growth Factor-1 (IGF-1)
Contrast RISK (Reducing Injury Sustained by Kidneys)
Maastricht Investigation of Renal Function in Absence of- and Post- Contrast in Patients With eGFR LEss Than 30
Data on the Prevention of Complications of Prophylactic Intravenous Hydration in Patients With eGFR < 30
Biomarkers of Acute Kidney Injury in Cardiac Surgery
Biomarker-guided Implementation of the AKI Bundle
Open-Label Safety, Tolerability, PK Study of IV CXA-10 Emulsion in Subjects in Chronic Kidney Injury
Study of CXA-10 in Healthy Volunteers
Comparison Between Right and Left Ventricular Systolic Dysfunction as a Risk Factors for Aki in Critical Care Patients
Exploring the Relationship Among BNP, Fluid Status and Acute Kidney Injury in Critically Ill Patients